3 Things to Watch at NPS Pharmaceuticals

By Brandy Betz NPS Pharmaceuticals (Nasdaq: NPSP  ) has been getting some love. A recent FDA advisory panel unanimously recommended approval for the company’s lead drug ...

Unleashing Biotech Innovation With The Currency of Entrepreneurship

By Bruce Booth The translation of cutting-edge science into new clinically-relevant therapeutics is the ultimate goal of many academic investigators, industry researchers, and investors.  ...

Pfizer – Old Company, Exciting New Catalysts

By Stock Whisper On Wednesday, Dec. 5, Pfizer (PFE) released positive test data for PD-0332991, a drug aimed mainly at breast cancer. The stock appreciated approximately 30 cents on ...

Prolor Biotech: A Critical Year For Company With Results Expected For Lead Drug In Development

By Josh Hutheson Following a strong rally in the first six weeks of 2012, Prolor Biotech’s (PBTH) shares have fallen apart and are now down more than 25% from 2012 highs compared ...

Buying Teva’s Immunotherapy Investment

By James Stocklasar Thomas Jr. Teva Pharmaceuticals (TEVA) is one of the behemoths in the pharmaceutical industry with a strategic commitment to the growing acceptance of immunotherapy ...

Alexza Is Meaningfully Overvalued Following Its Latest Rally

By  PropThink On Dec. 21, 2012, the U.S. FDA is expected to rule on Alexza Pharmaceuticals’ (ALXA) new drug application (NDA) for ADASUVE, the company’s inhalation powder ...

Ranbaxy Sued Over Generic Lipitor Recall

 By Ed Silverman Should Ranbaxy Laboratories have notified consumers of its decision to recall generic Lipitor because glass particles were found in some lots? One New Jersey man thinks ...

Cigarette warning issue may go to Supreme Court

By Cheryl Wetzstein The legal battle over graphic labels on cigarette packages edged closer to the U.S. Supreme Court on Wednesday, as a federal appellate court declined to reconsider ...

UPDATE 1-U.S. IRS finalizes new tax for medical devices in healthcare law

(Reuters) – The U.S. Internal Revenue Service on Wednesday released final rules for a new tax on medical devices, products ranging from surgical sutures to knee replacement implants, ...

Bacteria in antiseptic skin prep? FDA ponders sterility

By JoNel Aleccia Two years after the death of a Texas toddler that focused national attention on the contamination of alcohol wipes used widely in hospitals and homes, federal health ...

Feds Tighten Salmonella Controls for Ground Poultry in Wake of Recent Outbreaks

BY GRETCHEN GOETZ After two nationwide Salmonella outbreaks linked to ground turkey sickened at least 148 people last year, the federal government has decided to implement stricter ...

Top EU court upholds AstraZeneca fine over ulcer drug

By Foo Yun Chee and Ben Hirschler (Reuters) – The European Union’s highest court has upheld a 52.5 million euro ($69 million) antitrust fine levied against AstraZeneca ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS